Insider Trading & Ownership - Arbet-Engels Christophe

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Arbet-Engels Christophe
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-01-24
Sale
2025-01-27
6:15 pm
X4 Pharmaceuticals Inc XFOR Arbet-Engels Christophe
Chief Medical Officer
11,624 $0.4546 $5,284 14,207
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-02-12
Option Award
2025-02-14
4:09 pm
N/A
N/A
X4 Pharmaceuticals Inc XFOR Arbet-Engels Christophe
Chief Medical Officer
850,000 $0 864,207
(Direct)
View
2025-01-23
Option Award
2025-01-27
6:15 pm
N/A
N/A
X4 Pharmaceuticals Inc XFOR Arbet-Engels Christophe
Chief Medical Officer
25,831 $0 14,207
(Direct)
View
2024-02-13
Option Award(A)
2024-02-28
5:52 pm
N/A
2034-02-13
X4 Pharmaceuticals Inc XFOR Arbet-Engels Christophe
Chief Medical Officer
180,816 $0 180,816
(Direct)
View
2024-02-13
Option Award
2024-02-16
5:11 pm
N/A
2034-02-13
X4 Pharmaceuticals Inc XFOR Arbet-Engels Christophe
Chief Medical Officer
475,831 $0 475,831
(Direct)
View
2023-08-31
Option Award
2023-09-05
4:15 pm
N/A
2033-08-30
X4 Pharmaceuticals Inc XFOR Arbet-Engels Christophe
Chief Medical Officer
1,250,000 $1.28 1,250,000
(Direct)
View
2020-05-25
Option Award
2020-05-27
9:38 pm
N/A
2030-05-24
Millendo Therapeutics Inc. MLND Arbet-Engels Christophe
Chief Medical Officer
80,000 $0 80,000
(Direct)
View
(A) Indicate amendment filing.